HTT and Huntington disease: In summary, here, we demonstrate suppression of glial activation, reduction in huntingtin pathology and improvement in locomotor activities in a mouse model of HD by nebulized aspirin at a dose of 10 μg/mouse/d or 0.4 mg/kg body wt/d, which is roughly equivalent to 28 mg/adult/day.